OpenLegislation

Chapter 5 POST-AUTHORISATION REQUIREMENTSF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 14Post-authorisation follow-up of efficacy and adverse reactions, and risk management
  2. 15Traceability

Annotations

Textual amendments

F1

Regulation revoked (in so far as it applies to medicinal products for human use) (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(o) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)